Drawing for AVACC

USPTO serial 79330273

AVACC

Reviewed by CopyMark Law Group

Reg. 7051122Status 700Registered
Filing date
Status date
Registration date
May 16, 2023
Examiner
FRUM MILONE, MARCIE R
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AVACC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey H. Greger

Jeffrey H. Greger STUDEBAKER BRACKETT PLLC8255 Greensboro DriveSuite 300Tysons, VA 22102

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products and preparations for prevention, treatment and immune therapy and combinations of prevention, treatment and immune therapy of infectious diseases and allergic diseases, as well as pharmaceutical products and preparations against cancer; vaccines; and medicines for human use for prevention, treatment and immune therapy and combinations of prevention, treatment and immune therapy of infectious diseases, allergic diseases and cancer; bacterial and viral vaccines, synthetic, recombinant, peptide, protein, RNA-, DNA- and therapeutic vaccines; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibodies; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibody drug conjugatesACTIVE—
010Apparatus and containers for the administration of vaccines and medicines, namely, cups for dispensing medicine, injection needles for the administration of vaccines and medicines, injection instruments without needles for the administration of vaccines and medicines, nose sprayers for medical purposes, and spray syringes for medical purposes; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibodies; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibody drug conjugatesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 21, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 21, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 12, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 21, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 21, 2023FIMPFINAL DISPOSITION PROCESSED—
Aug 16, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 16, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 16, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 28, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 28, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2023GPNXNOTIFICATION PROCESSED BY IB—
Feb 8, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 8, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 8, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 20, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 20, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jan 20, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 20, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 20, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 6, 2023LIMELIMITATION FROM THE IB - REQUEST EXAM REVIEW—
Oct 3, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 27, 2022LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jun 7, 2022RFNTREFUSAL PROCESSED BY IB—
May 16, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 16, 2022RFRRREFUSAL PROCESSED BY MPU—
Apr 1, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 31, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2022DOCKASSIGNED TO EXAMINER—
Jan 11, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 7, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 6, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance